We're not a chain
Because the circuits are partly distinct, the effects tend to add rather than overlap, and the combination can deliver more total appetite suppression at amounts that neither compound would need to reach alone
A tiny drop of medication at the injection site after withdrawal is normal and represents an insignificant amount
Regular follow-ups are vital to monitor glycemic response , weight changes , and overall tolerance
Weight Loss Injections We Offer At Foundation Pain & Spine, we provide weight management injections like Semaglutide and Tirzepatide to support safe and effective weight loss

UHCs typical prior authorization requirements for Wegovy and Zepbound include: BMI documentation A documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity evidence Clinical records documenting the specific comorbidities that support the medical necessity of treatment Supervised weight management history Evidence of participation in a structured weight management program, which may include diet, exercise, and behavioral counseling, typically for 3 to 6 months prior to the request Prescriber qualifications The prescriber must be a physician, nurse practitioner, or physician assistant with appropriate prescribing authority UHC reviews prior authorizations against specific clinical policy bulletins